Demetrix, Inc. Competitors or Alternatives

Demetrix, Inc.'s top competitors include Emerald Health, MedReleaf and Zynerba.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Demetrix, Inc.'s company profile

Jeff Ubersax

CEO

90/100
$59M
$100K - 5M
1
Demetrix, Inc.'s Competitor - Emerald Health logo

Riaz Bandali

President & CEO

90/100
161
$41.4M
$53.9M
2
Demetrix, Inc.'s Competitor - MedReleaf logo

CEO

- -
100 - 250
$75M
$25M - 100M
3
Demetrix, Inc.'s Competitor - Zynerba logo

Armando Anido

Chairman & CEO

90/100
25 - 100
$75M
4
Demetrix, Inc.'s Competitor - Supreme Cannabis logo

Beena Goldenberg

President & CEO

86/100
250 - 500
$305.6M
$25M - 100M
5
Demetrix, Inc.'s Competitor - CannTrust logo

Greg Guyatt

CEO

90/100
576
$142.9M
$42.1M

Demetrix, Inc. VS Emerald Health

Emerald Health is one of Demetrix, Inc.'s top competitors. Emerald Health was founded in 2007, and its headquarters is in Victoria, British Columbia. Like Demetrix, Inc., Emerald Health also works within the Pharmaceuticals & Biotechnology sector. Emerald Health has 161 more employees than Demetrix, Inc..

Demetrix, Inc. VS MedReleaf

MedReleaf is Demetrix, Inc.'s #2 rival. MedReleaf was founded in 2013 in Markham, Ontario. MedReleaf operates in the Health Care Services industry. MedReleaf generates $29.6M more revenue than Demetrix, Inc..

Demetrix, Inc. VS Zynerba

Zynerba is a top competitor of Demetrix, Inc.. Zynerba is a Private company that was founded in Devon, Pennsylvania in 2007. Zynerba is in the Pharmaceuticals field. Zynerba has 27 more employees vs. Demetrix, Inc..

Frequently Asked Questions about Demetrix, Inc.

  1. Who are Demetrix, Inc.'s top competitors?

    Demetrix, Inc.'s top 3 competitors are Emerald Health, MedReleaf, Zynerba.
  2. Who is similar to Demetrix, Inc.?

    Emerald Health is the most similar to Demetrix, Inc.. MedReleaf and Zynerba are also similar to Demetrix, Inc..
  1. Are Demetrix, Inc. and Emerald Health competitors?

    Yes, Emerald Health is one of Demetrix, Inc.’s top competitors.